Related Experiment Video

Updated: Jul 7, 2026

Focus Formation: A Cell-based Assay to Determine the Oncogenic Potential of a Gene
08:18

Focus Formation: A Cell-based Assay to Determine the Oncogenic Potential of a Gene

Published on: December 31, 2014

Disruption of the MYC transcriptional function by a small-molecule antagonist of MYC/MAX dimerization

Xiaohong Lu1, Peter K Vogt, Dale L Boger

  • 1Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, NE2 4HH, UK.

Oncology Reports
|February 22, 2008
PubMed

Insights

A novel reporter gene assay shows that the small molecule IIA6B17 selectively inhibits MYCC activity in neuroepithelioma cells, not neuroblastoma cells. This suggests targeted therapeutic potential for MYC family oncoprotein inhibitors.

Area of Science:

  • Oncology
  • Molecular Biology
  • Drug Discovery

Background:

  • MYC/MAX dimerization is crucial for MYC oncoprotein function.
  • Small-molecule inhibitors targeting MYC/MAX dimerization show therapeutic potential.
  • Developing selective inhibitors for MYC family members is critical for cancer therapy.

Purpose of the Study:

  • To develop a functional MYC reporter gene assay.
  • To evaluate the cell-specific activity of the MYC/MAX dimerization inhibitor IIA6B17.
  • To assess the therapeutic potential of IIA6B17 in MYC-driven cancers.

Main Methods:

  • Developed a MYC functional reporter gene assay using a luciferase construct under the ornithine decarboxylase (ODC) promoter.
  • Stably transfected the reporter construct into MYCN-amplified neuroblastoma (NGP) and MYCC-overexpressed neuroepithelioma (NB100) cell lines.
  • Assessed the effect of IIA6B17 on luciferase activity in transfected cell lines after 24-hour exposure.

Main Results:

  • IIA6B17 significantly reduced luciferase activity in NB100 cells (MYCC-overexpressed) with an IC50 of approximately 28+/-9 microM.
  • No significant reduction in luciferase activity was observed in NGP cells (MYCN-amplified).
  • IIA6B17 demonstrated cell line-specific activity, suggesting selectivity for individual MYC family members.

Conclusions:

  • The developed reporter gene assay is effective for evaluating MYC functional activity.
  • IIA6B17 exhibits selective inhibition of MYCC activity in neuroepithelioma cells.
  • IIA6B17 shows potential as a targeted therapeutic agent for cancers driven by specific MYC family members.

More Related Videos

Identification of MyoD Interactome Using Tandem Affinity Purification Coupled to Mass Spectrometry14:47

Identification of MyoD Interactome Using Tandem Affinity Purification Coupled to Mass Spectrometry

Published on: May 17, 2016

Inducible and Reversible Dominant-negative (DN) Protein Inhibition08:35

Inducible and Reversible Dominant-negative (DN) Protein Inhibition

Published on: January 7, 2019

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...